(Press-News.org) Some of the final work of a late University of Virginia School of Medicine scientist has opened the door for life-saving new treatments for solid cancer tumors, including breast cancer, lung cancer and melanoma.
Prior to his sudden death in 2016, John Herr, PhD, had been collaborating with UVA Cancer Center’s Craig L. Slingluff Jr., MD, to investigate the possibility that a discovery from Herr’s lab could help treat cancer.
Eight years of research has borne that idea out: Herr’s research into the SAS1B protein could lead to “broad and profound” new treatments for multiple cancers, many of which are very difficult to treat, Slingluff reports in a new scientific paper in the Journal for ImmunoTherapy of Cancer. Herr is listed as a senior author on the paper.
“John was very excited about this protein SAS1B to be a valuable new target on human cancers, and I am delighted that our findings together further support his hope to make such a difference,” said Slingluff, a surgical oncologist and translational immunologist at UVA Health and the UVA School of Medicine. “The work we published included work done by Dr. Herr and his team over a period of years, as well as our subsequent work together; so, I am glad that the journal agreed with our request to include John as a senior author.”
Promising New Cancer Target
Herr’s lab was not originally focused on cancer -- he was the head of UVA’s Center for Research in Contraceptive and Reproductive Health. In that role, he developed the first home fertility test for men, SpermCheck, which is available in pharmacies across the country. But his discoveries about the SAS1B protein found in developing eggs in women could pave the way for new cancer immunotherapies.
While SAS1B is found inside female reproductive cells called oocytes, it is also found on the surface of many different solid cancer cells, Slingluff’s new research verifies. Importantly, it did not appear on the surface of any of the other normal cells Slingluff’s laboratory tested. That suggests that doctors may be able to develop use antibody-based immunotherapy – such as antibody-drug conjugates or CAR T-cell therapy, a strength of UVA Health – to attack the cancer cells while sparing healthy tissue.
“Selectively targeting SAS1B has the potential to have broad and profound impact on the treatment, and therefore reduction in mortality, of multiple malignancies,” Slingluff and his colleagues write in their new paper.
While much more work needs to be done, the new findings are promising. If the approach is successful, it could be a big step forward in cancer care. Many solid-organ cancers are extremely difficult to treat, and patients often have few good treatment options, Slingluff notes.
“Immune therapy is revolutionizing treatment of human cancers,” Slingluff said. “But some cancers have been particularly resistant to immune therapy because of the lack of good targets on those cancers. We hope that this work that John Herr started will bring new hope to patients with those cancers.”
Finding new ways to improve cancer care is a foundational mission of UVA Cancer Center, one of only 56 cancer centers to receive “comprehensive” designation from the National Cancer Institute. The designation honors elite cancer centers with the most outstanding cancer care and research programs in the country.
Advancing the field of immunotherapy is also a key mission of UVA’s forthcoming Paul and Diane Manning Institute of Biotechnology. Now under construction at Fontaine Research Park, the institute is poised to accelerate the development of new treatments and cures for a wide variety of diseases, ultimately transforming how healthcare is delivered across Virginia and beyond.
About the Research
Slingluff’s collaborators on the new paper consisted of Arabinda Mandal, Jagathpala Shetty, Christine A. Tran, Walter C. Olson, Mriganka Mandal, Bhupal Ban, Eusebio S. Pires, Sara J. Adair and Todd W. Bauer. Herr is also credited on the paper – he and Slingluff are listed as joint senior authors.
The research was supported by the Cancer Research Institute; the Grand Challenges Exploration Program from the Bill and Melinda Gates Foundation; the Wallace H. Coulter Translation Research Partnership Endowment; the Virginia Center for Innovative Technology; the National Cancer Institute, grants P30 CA044579 and T32 CA163177; and by the National Institutes of Health’s National Heart, Lung and Blood Institute, grant T32 HL007849.
UVA has filed patent applications on the use of SAS1B as a cancer drug and diagnostic target. Slingluff has received research support from Celldex, Glaxo-Smith Kline, Merck, 3M and Theraclion, and he receives licensing fees through the UVA Licensing and Ventures Group for patents for peptides used in cancer vaccines. A full list of the authors’ disclosures is included in the paper.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.
END
Years after his death, late scientist's work could yield new cancer treatments
2024-05-07
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
SwRI evaluates reliability of pressure relief valves for liquid natural gas tanks in train derailment scenarios
2024-05-07
SAN ANTONIO — May 7, 2024 —Southwest Research Institute (SwRI) has helped determine the viability of pressure relief valves for liquid natural gas tanks in the event of a train derailment for the Federal Rail Administration (FRA). The report from the FRA shows that a study conducted by SwRI demonstrates that the pressure relief valves work as designed to prevent overpressurization and explosion if a derailment occurs.
“The pressure relief valves on tanks that transport liquid ...
Study: You’re breathing potential carcinogens inside your car
2024-05-07
The air inside all personal vehicles is polluted with harmful flame retardants—including those known or suspected to cause cancer—according to a new peer-reviewed study published in Environmental Science & Technology. Car manufacturers add these chemicals to seat foam and other materials to meet an outdated federal flammability standard with no proven fire-safety benefit.
“Our research found that interior materials release harmful chemicals into the cabin air of our cars,” said lead author Rebecca ...
Using AI to predict GPA from college application essays
2024-05-07
Jonah Berger and Olivier Toubia used natural language processing to understand what drives academic success. The authors analyzed over 20,000 college application essays from a large public university that attracts students from a range of racial, cultural, and economic backgrounds and found that the semantic volume of the writing, or how much ground an application essay covered predicted college performance, as measured by grade point average. Essays that covered more semantic ground predicted higher grades. Similarly, essays with smaller conceptual jumps between successive parts of ...
Few tenure-track jobs for engineering PhDs
2024-05-07
A study finds that most engineering PhD graduates will never secure a tenure-track faculty position. Over the past 50 years, the number of full-time faculty positions in US universities has steadily declined while production of science and engineering PhD graduates has nearly doubled. Siddhartha Roy and colleagues analyzed data on PhD graduates and tenure-track and tenured faculty members across all engineering disciplines from 2006–2021. The average annual likelihood of securing a tenure-track faculty position in engineering during this 16-year period was 12.4%. The likelihood of securing a tenure-track faculty position was 18.5% in ...
Hidden citations in physics
2024-05-07
In the scientific literature, a citation acts as a mechanism to signal prior knowledge, enhance credibility, and protect against plagiarism. But it also gives credit to the individual or team who established or discovered the knowledge in question, and citations have thus emerged as a metric to measure the impact of a work or researcher. However, when a discovery or technique becomes common knowledge, scientists often stop bothering to cite it. Thus, the most impactful work is often undercited. Albert-László Barabási ...
Wildfire risk management in the era of climate change
2024-05-07
A Perspective explores lessons learned from recent deadly wildfires and proposes a strategy for managing wildfire risk. Wildfire risk and wildfire deaths are on the rise due to climate change, policies of fire suppression, and development in the wildland-urban interface. The August 8, 2023, fire that destroyed the historic town of Lahaina, Hawaii, claimed 98 lives, in part due to a failure to alert residents to the danger. In 2018, 104 lives were lost in a fire in Mati, Greece, for which there were also no alerts. For both ...
A smart neckband for tracking dietary intake
2024-05-07
A smart neckband allows wearers to monitor their dietary intake. Automatically monitoring food and fluid intake can be useful when managing conditions including diabetes and obesity, or when maximizing fitness. But wearable technologies must be able to distinguish eating and drinking from similar movements, such as speaking and walking. Chi Hwan Lee and colleagues propose a machine-learning enabled neckband that can differentiate body movements, speech, and fluid and food intake. The neckband’s sensor module includes ...
Gut bacteria metabolite shows promise of fighting inflammatory bowel disease
2024-05-07
Gut microbiota or the population of microbial inhabitants in the intestine, plays a key role in digestion and maintenance of overall health. Any disturbance in the gut microbiota can, therefore, have a systemic impact. Intestinal microbes metabolize dietary components into beneficial fatty acids (FAs), supporting metabolism and maintaining host body homeostasis. Metabolites originating from polyunsaturated fatty acids (PUFAs), influenced by gut microbes such as Lactobacillus plantarum, exhibit potent effects on ...
Breakthrough paves the way for next generation of vision implants
2024-05-07
A group of researchers from Chalmers University of Technology in Sweden, University of Freiburg and the Netherlands Institute for Neuroscience have created an exceptionally small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the blind.
Often when a person is blind, some or part of the eye is damaged, but the visual cortex in the brain is still functioning and waiting for ...
New study finds increase in exposures to synthetic tetrahydrocannabinols among young children, teens, and adults
2024-05-07
(COLUMBUS, Ohio) – A sharp rise in exposures to synthetic cannabis products among youth — some leading to hospitalization — highlights the need for increased education around the dangers of exposure and increased focus on safe storage and packaging, according to pediatricians and researchers at Nationwide Children’s Hospital and the Central Ohio Poison Center.
A new study conducted by researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital and the Central Ohio Poison Center examined trends in calls to poison ...